Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × NETWORK × Re-Irradiation × Clear all

Phase

Phase NA 1 Phase 3 1

Status

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Radiotherapy 124 Cyclophosphamide 99 Cisplatin 96 Doxorubicin 91 Vincristine 69 Filgrastim 55 Etoposide 53 Paclitaxel 51 Carboplatin 50 Fluorouracil 48 Methotrexate 45 Dexamethasone 43 Prednisone 38 Cytarabine 38 Leucovorin 35 Granulocyte Colony-Stimulating Factor 31 Docetaxel 31 Radiation 27 Ifosfamide 25 Tamoxifen 24 Daunorubicin 23 Calcium Dobesilate 23 Specimen Handling 22 Gemcitabine 21 Platinum 20 Mercaptopurine 20 Magnetic Resonance Spectroscopy 20 Chemotherapy, Adjuvant 20 1,2-diaminocyclohexaneplatinum II citrate 20 Goserelin 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05904119 2026-02-17

LEGATO

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡